On Tuesday, the U.S. Food and Drug Administration approved a device to continuously monitor blood sugar and ketone levels in ...
Smart rings are everywhere: smart rings that can record your verbal notes and send them to your cellular telephone for ...
The FDA authorized the Libre Duo 10 Day Continuous Dual Glucose-Ketone Monitoring System for people ages 2 years and older ...
Diabetes patients' lives could be about to get safer following the granting of regulatory approval for a world-first wearable ...
People with diabetes can now get an early warning when a dangerous complication starts to build in their bodies.
Abbott Laboratories (NYSE:ABT) received FDA De Novo authorization for its Libre Duo 10 Day, described as the first dual ...
Libre Duo 10 Day is a first-of-its-kind, two-in-one biowearable that monitors glucose and helps detect rising ketone levels ...
Abbott plans to roll out the device, called Libre Duo 10 Day, later this year. The sensor can measure both glucose and ...
The FDA authorized Abbott’s Libre Duo 10 Day on August 25, the first U.S. wearable to continuously monitor both ketones and ...
The FDA authorizes the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System as the first device of its kind for ...
As Abbott prepares to launch its first dual-analyte sensor, endocrinologists talked to MedTech Dive about considerations for ...